title: Candida peritonitis in dogs: report of 5 cases.
abstract: Candida peritonitis is reported in people and is associated with significant morbidity and mortality compared with sterile or bacterial peritonitis. Recognized predisposing risk factors include peritoneal dialysis, hollow viscous organ perforation, abdominal surgery, inflamed intestinal mucosa, antimicrobial administration, and immunosuppression. In this report, we describe 5 cases of dogs with peritonitis complicated by Candida spp; 3 dogs with C albicans, one dog with C albicans and C glabrata, and one dog with C glabrata only. The 3 dogs with C albicans peritonitis presented with duodenal perforation due to NSAID therapy, intestinal resection and anastomosis following postspay-surgery dehiscence, and intestinal foreign body removal. The 2 dogs with C glabrata peritonitis had undergone cholecystectomy due to gall bladder rupture and dehiscence of intestinal biopsy removal sites following exploratory laparatomy. In all cases, initial diagnosis of fungal peritonitis was made via cytologic examination of peritoneal effusions, which revealed marked pyogranulomatous inflammation with numerous 3-8 μm oval, deeply basophilic yeast organisms with thin clear capsules noted within phagocytes and extracellularly. In addition, germ tube formation, hyphae, and pseudohyphae were rarely seen in some of the cases with pure C albicans. Identity of the organisms was determined by culture in all cases and confirmed by PCR in 3 cases. Candida spp. are commensals normally inhabiting the alimentary, the upper respiratory, and the lower urogenital tracts of mammals. They are opportunistic pathogens that can invade and colonize tissue when a patient is immune-compromised or there is disruption of the mucosal barrier. Candida peritonitis should be considered in patients with peritoneal contamination with gastrointestinal or biliary contents.
authors.affiliation: Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA. katy.jacocks@okstate.edu
authors.forename: Katy
authors.initials: K
authors.lastname: Bradford
authors.forename: Jim
authors.initials: J
authors.lastname: Meinkoth
authors.forename: Kelci
authors.initials: K
authors.lastname: McKeirnen
authors.forename: Brenda
authors.initials: B
authors.lastname: Love
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000382:microbiology / Q000473:pathology*; D001659:Biliary Tract / Q000382:microbiology; D002175:Candida / Q000235:genetics / Q000302:isolation & purification*; D002177:Candidiasis / Q000382:microbiology / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D004283:Dog Diseases / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D004285:Dogs; D017809:Fatal Outcome; D005260:Female; D041981:Gastrointestinal Tract / Q000382:microbiology; D025301:Hyphae; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D010538:Peritonitis / Q000382:microbiology / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D010586:Phagocytes; D016133:Polymerase Chain Reaction
chemical_list: D000935:Antifungal Agents